Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan

Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan

Background: Levosimendan improves clinical and hemodynamic parameters exerting an anti-inflammatory and antiapoptotic effect in decompensated heart failure. The aim of this study was to evaluate the effects of levosimendan on LV torsion, plasma levels of NT-proBNP and on the balance between pro-infl...

Full description

Bibliographic Details
Main Authors:	Romina Navarri, Stefano Lunghetti, Matteo Cameli, Sergio Mondillo, Roberto Favilli, Francesca Scarpini, Luca Puccetti
Format:	Article
Language:	English
Published:	Elsevier 2015-06-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	Heart failure Levosimendan Strain echocardiography Cytokines
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906714000815

Similar Items

Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery
by: Kaushik Jothinath, et al.
Published: (2021-01-01)

Levosimendan. A promising future drug for refractory cardiac failure in children?
by: Supriya Kushwah, et al.
Published: (2016-04-01)

Efficacy of levosimendan vs dopamine in patients with resistant cardiac failure
by: Nino Amiranovna Dzhaiani, et al.
Published: (2011-06-01)

The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
by: N. B. Lebedeva, et al.
Published: (2022-05-01)

Venoarterial extracorporeal membrane oxygenation in combination with Levosimendan as a bridge to recovery for a case of severe yew intoxication in a 13‐year‐old patient
by: Eva Maria Peer, et al.
Published: (2023-12-01)

Levosimendan na insuficiência cardíaca descompensada: revisão sistemática e metanálise Levosimendan in acute decompensated heart failure: systematic review and meta-analysis
by: Rodrigo Antonini Ribeiro, et al.
Published: (2010-08-01)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
by: Daniele Masarone, et al.
Published: (2022-10-01)

The effect of levosimendan on the right ventricular function in patients with right ventricular dysfunction undergoing mitral valve surgery
by: K S Bharathi, et al.
Published: (2023-01-01)

Use of levosimendan in acute and advanced heart failure: short review on available real-world data
by: Pashkovetsky E, et al.
Published: (2019-06-01)

LEVOSIMENDAN FOR INTENSIVE THERAPY OF HEART FAILURE IN HEART VALVE PROSTHETICS
by: O. N. Ulitkina, et al.
Published: (2016-02-01)

Análise de custos do tratamento de episódios de descompensação aguda de insuficiência cardíaca: levosimendan versus dobutamina Cost analysis of the treatment of acute decompensated heart failure: levosimendan versus dobutamine
by: Mucio Tavares Oliveira Jr, et al.
Published: (2005-07-01)

Levosimendan for patients with heart failure undergoing major oncological surgery: A randomised blinded pilot study
by: Ehab H Shaker, et al.
Published: (2019-01-01)

Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia
by: Carolin Torregroza, et al.
Published: (2021-04-01)

Role of inhaled levosimendan in peripartum cardiomyopathy
by: Parminder Kaur, et al.
Published: (2022-01-01)

Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction
by: Gabriele Tumminello, et al.
Published: (2021-10-01)

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
by: David Dobarro, et al.
Published: (2023-04-01)

Exercise Capacity Is Improved by Levosimendan in Heart Failure and Sarcopenia via Alleviation of Apoptosis of Skeletal Muscle
by: Di Wang, et al.
Published: (2022-01-01)

Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy
by: Vasiliki Tsolaki, et al.
Published: (2023-06-01)

Levosimendan in lung transplant recipients on VA‑ECMO
by: S. V. Zhuravel, et al.
Published: (2020-04-01)

Novel echocardiographic techniques to assess left atrial size, anatomy and function
by: Cameli Matteo, et al.
Published: (2012-02-01)

IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01)

Levosimendan attenuates myocardial injury induced by coronary microembolization in swine by inhibiting myocardial inflammation and apoptosis
by: Han Chen, et al.
Published: (2019-01-01)

The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia
by: Roehl Anna B, et al.
Published: (2012-08-01)

Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study
by: Martín J. García‐González, et al.
Published: (2021-12-01)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
by: William Juguet, et al.
Published: (2020-11-01)

Levosimendan is superior to epinephrine on coronary flow for lipid-base resuscitation of bupivacaine-induced asystole in the isolated rat heart
by: Hongfei Chen, et al.
Published: (2018-11-01)

Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
by: Amitai Segev, et al.
Published: (2022-06-01)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
by: Enrique Guilherme, et al.
Published: (2020-07-01)

Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study
by: Anders Lund Selli, et al.
Published: (2023-10-01)

The Use of Levosimendan after Out-of-Hospital Cardiac Arrest and Its Association with Outcome—An Observational Study
by: Susanne Rysz, et al.
Published: (2022-05-01)

Ultrasound assessment of diaphragmatic dysfunction and its improvement with levosimendan in patients with chronic obstructive pulmonary disease
by: Clarissa Anna De Rosa, et al.
Published: (2023-03-01)

Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study
by: Kunecki Marcin, et al.
Published: (2022-12-01)

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial
by: Omar Ellouze, et al.
Published: (2021-08-01)

Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit
by: Shamir Vally, et al.
Published: (2019-02-01)

Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double‐Blind Controlled Trial
by: Lukas Lannemyr, et al.
Published: (2018-08-01)

Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology
by: Eduarda Ribeiro, et al.
Published: (2023-08-01)

Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study
by: Joanna Sikora, et al.
Published: (2024-02-01)

Inhaled levosimendan versus intravenous levosimendan in patients with pulmonary hypertension undergoing mitral valve replacement
by: Tanveer Singh Kundra, et al.
Published: (2018-01-01)

Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study
by: Cze-Ci Chan, et al.
Published: (2021-02-01)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
by: Basil John, Pharm D, et al.
Published: (2021-05-01)